D Shen1, X Zhang2, Z Li3, H Bai1, L Chen3. 1. a Department of Nutrition and Food Hygiene, School of Public Health , Shandong University , Jinan , China. 2. b Department of Telemedicine Center , Shandong Provincial Hospital Affiliated to Shandong University , Jinan , China. 3. c Department of Nutrition , Shandong Provincial Hospital Affiliated to Shandong University , Jinan , China.
Abstract
AIM: There is conflicting evidence regarding the effects of omega-3 fatty acids on bone turnover markers in postmenopausal women. Thus, we systematically reviewed the efficacy of omega-3 fatty acids by conducting a meta-analysis of available randomized controlled trials. METHODS: PubMed, Embase, Cochrane Library and Scopus were searched in December 2016. The standardized mean difference (SMD) or weighted mean difference (WMD) and the corresponding 95% confidence intervals (CIs) were calculated using a fixed-effects model. RESULTS: Eight trials were included in the present meta-analysis. The pooled findings did not identify significant decreases in bone-specific alkaline phosphatase (SMD -0.08, 95% CI -0.29 to 0.12, p = 0.429) and collagen type I cross-linked C-telopeptide (WMD 0 ng/ml, 95% CI -0.04 to 0.04, p = 0.899). There was a significant decrease in osteocalcin (WMD -0.86 ng/ml, 95% CI -1.68 to -0.04, p = 0.040) as compared with control. CONCLUSION: Omega-3 fatty acids reduced postmenopausal women's serum osteocalcin. Further well-designed studies are needed to verify the effects of omega-3 fatty acids on bone mass density and other bone turnover markers in postmenopausal women. CLINICAL TRIAL REGISTRATION NUMBER: CRD42016053219 ( https://www.crd.york.ac.uk/PROSPERO/ ).
AIM: There is conflicting evidence regarding the effects of omega-3 fatty acids on bone turnover markers in postmenopausal women. Thus, we systematically reviewed the efficacy of omega-3 fatty acids by conducting a meta-analysis of available randomized controlled trials. METHODS: PubMed, Embase, Cochrane Library and Scopus were searched in December 2016. The standardized mean difference (SMD) or weighted mean difference (WMD) and the corresponding 95% confidence intervals (CIs) were calculated using a fixed-effects model. RESULTS: Eight trials were included in the present meta-analysis. The pooled findings did not identify significant decreases in bone-specific alkaline phosphatase (SMD -0.08, 95% CI -0.29 to 0.12, p = 0.429) and collagen type I cross-linked C-telopeptide (WMD 0 ng/ml, 95% CI -0.04 to 0.04, p = 0.899). There was a significant decrease in osteocalcin (WMD -0.86 ng/ml, 95% CI -1.68 to -0.04, p = 0.040) as compared with control. CONCLUSION:Omega-3 fatty acids reduced postmenopausal women's serum osteocalcin. Further well-designed studies are needed to verify the effects of omega-3 fatty acids on bone mass density and other bone turnover markers in postmenopausal women. CLINICAL TRIAL REGISTRATION NUMBER: CRD42016053219 ( https://www.crd.york.ac.uk/PROSPERO/ ).
Entities:
Keywords:
Omega-3 fatty acids; bone turnover markers; meta-analysis; postmenopausal women
Authors: Orlagh Feehan; Pamela Jane Magee; Laura Kirsty Pourshahidi; David John Armstrong; Mary Martina Slevin; Philip James Allsopp; Marie Catherine Conway; J J Strain; Emeir Mary McSorley Journal: Eur J Nutr Date: 2022-07-30 Impact factor: 4.865